DNLI
Denali TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
DNLI vs peer average
84/100
DNLI vs. peer average (A vs. C)
Grade spread
B 3 · C 4 · D 2 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ACAD is the first available peer comparator.
Smaller CNS-focused company with commercial experience; illustrative peer for commercialization and market reception risk.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
DNLI
Denali Therapeutics
ACAD
ACADIA
Grade
A
C
Momentum
47
27
Value
41
62
Sentiment
100
75
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs ACAD
DNLI / ACAD
Grade Position
Above peers
DNLI vs. peer average (A vs. C)
84/100
Momentum
47
DNLIValue
41
ACADSentiment
100
DNLIRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs DNLI
ACAD is the first peer returned for this comparison set.